APA (7th ed.) Citation

Shimelis, H., Arndt, V., Brenner, H., Burwinkel, B., Chang-Claude, J., Hamann, U., & Marmé, F. (2017). BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer research, 77(11), . https://doi.org/10.1158/0008-5472.CAN-16-2568

Chicago Style (17th ed.) Citation

Shimelis, Hermela, Volker Arndt, Hermann Brenner, Barbara Burwinkel, Jenny Chang-Claude, Ute Hamann, and Frederik Marmé. "BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer." Cancer Research 77, no. 11 (2017). https://doi.org/10.1158/0008-5472.CAN-16-2568.

MLA (9th ed.) Citation

Shimelis, Hermela, et al. "BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer." Cancer Research, vol. 77, no. 11, 2017, https://doi.org/10.1158/0008-5472.CAN-16-2568.